mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.04 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.05 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.05 |
mRNA |
FR-180204 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.05 |